EYENOVIA, INC. Files 8-K Report

Ticker: HYPD · Form: 8-K · Filed: Jun 4, 2024 · CIK: 1682639

Eyenovia, INC. 8-K Filing Summary
FieldDetail
CompanyEyenovia, INC. (HYPD)
Form Type8-K
Filed DateJun 4, 2024
Risk Levellow
Pages2
Reading Time2 min
Key Dollar Amounts$0.0001
Sentimentneutral

Sentiment: neutral

Topics: sec-filing, 8-k, disclosure

TL;DR

EYENOVIA filed an 8-K, likely containing important updates for investors.

AI Summary

On June 4, 2024, EYENOVIA, INC. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No specific financial figures or material events were detailed in the provided excerpt.

Why It Matters

This filing indicates that EYENOVIA, INC. is providing updates or disclosures to the SEC, which could contain important information for investors.

Risk Assessment

Risk Level: low — The provided text is a standard SEC filing notification and does not contain specific material events or financial data that would indicate a high-risk situation.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing for EYENOVIA, INC.?

The filing is primarily for Regulation FD Disclosure and to report Financial Statements and Exhibits.

What is EYENOVIA, INC.'s principal executive office address?

EYENOVIA, INC.'s principal executive offices are located at 295 Madison Avenue, Suite 2400, New York, NY 10017.

On what date was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing occurred on June 4, 2024.

What is EYENOVIA, INC.'s state of incorporation?

EYENOVIA, INC. is incorporated in Delaware.

What is the SIC code for EYENOVIA, INC.?

The Standard Industrial Classification (SIC) code for EYENOVIA, INC. is 2834, which corresponds to Pharmaceutical Preparations.

Filing Stats: 526 words · 2 min read · ~2 pages · Grade level 10.5 · Accepted 2024-06-04 07:24:51

Key Financial Figures

Filing Documents

01

Item 7.01. Regulation FD Disclosure. On June 4, 2024, Eyenovia, Inc. (the "Company") will begin using an updated corporate presentation with various investors and analysts. A copy of the presentation is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information contained in this Item 7.01, including Exhibit 99.1, is being "furnished" and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of that Section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended (the "Securities Act"). The information contained in this Item 7.01, including Exhibit 99.1, shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act or into any filing or other document pursuant to the Exchange Act, except as otherwise expressly stated in any such filing.

Financial Statements and Exhibits

Financial Statements and Exhibits. (d)Exhibits Exhibit No. Description 99.1 Eyenovia, Inc. Updated Corporate Presentation, dated June 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. EYENOVIA, INC. Date: June 4, 2024 /s/ John Gandolfo John Gandolfo Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing